No abstract available
Keywords:
Prevagen; adverse effects; apoaequorin; drug safety; efficacy; safety.
MeSH terms
-
Aequorin / adverse effects
-
Aequorin / therapeutic use*
-
Apoproteins / adverse effects
-
Apoproteins / therapeutic use*
-
Direct-to-Consumer Advertising
-
Humans
-
Marketing of Health Services
-
Memory / drug effects*
-
Nonprescription Drugs / adverse effects
-
Nonprescription Drugs / therapeutic use*
-
Nootropic Agents / adverse effects
-
Nootropic Agents / therapeutic use*
-
Recombinant Proteins / adverse effects
-
Recombinant Proteins / therapeutic use
-
Treatment Outcome
Substances
-
Apoproteins
-
Nonprescription Drugs
-
Nootropic Agents
-
Recombinant Proteins
-
apoaequorin
-
Aequorin